The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Open accessAbstract
OBJECTIVE: Accumulating evidence links the intestinal microbiota and colorectal carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and inhibit T cell-mediated immune responses against colorectal tumours. Thus, we hypothesised that the amount of F. nucleatum in colorectal carcinoma might be associated with worse clinical outcome. DESIGN: We used molecular pathological epidemiology database of 1069 rectal and colon cancer cases in the Nurses' Health Study and the Health Professionals Follow-up Study, and measured F. nucleatum DNA in carcinoma tissue. Cox proportional hazards model was used to compute hazard ratio (HR), controlling for potential confounders, including microsatellite instability (MSI, mismatch repair deficiency), CpG island methylator phenotype (CIMP), KRAS, BRAF, and PIK3CA mutations, and LINE-1 hypomethylation (low-level methylation). RESULTS: Compared with F. nucleatum-negative cases, multivariable HRs (95% CI) for colorectal cancer-specific mortality in F. nucleatum-low cases and F. nucleatum-high cases were 1.25 (0.82 to 1.92) and 1.58 (1.04 to 2.39), respectively, (p for trend=0.020). The amount of F. nucleatum was associated with MSI-high (multivariable odd ratio (OR), 5.22; 95% CI 2.86 to 9.55) independent of CIMP and BRAF mutation status, whereas CIMP and BRAF mutation were associated with F. nucleatum only in univariate analyses (p<0.001) but not in multivariate analysis that adjusted for MSI status. CONCLUSIONS: The amount of F. nucleatum DNA in colorectal cancer tissue is associated with shorter survival, and may potentially serve as a prognostic biomarker. Our data may have implications in developing cancer prevention and treatment strategies through targeting GI microflora by diet, probiotics and antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Self-citationGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationGarrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,080
Self-citationSystemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Cited by
Sorted by citations
Items 401–500 of 1,000
Löwenmark, T., Li, X., Löfgren‐Burström, A., Zingmark, C., Ling, A., Kellgren, T. G., Larsson, P. G., Ljuslinder, I., Wai, S. N., Edin, S., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03179-4 · Cited by 29
Xing, J., Liao, Y., Zhang, H., Zhang, W., Zhang, Z., Zhang, J., Wang, D., & Tang, D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.804689 · Cited by 29
Jin, M., Wu, J., Shi, L., Zhou, B., Shang, F., Chang, X., Dong, X., Deng, S., Liu, L., Cai, K., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.993285 · Cited by 29
Gut microbiome in tumorigenesis and therapy of colorectal cancer
Wang, L., Yu, K., Hou, Y., Guo, M., Yao, F., & Chen, Z. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30917 · Cited by 31
The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
Yu, I., Wu, R., Tokumaru, Y., Terracina, K. P., & Takabe, K. (2022) · Cancers · doi:10.3390/cancers14225685 · Cited by 30
Löwenmark, T., Löfgren‐Burström, A., Zingmark, C., Ljuslinder, I., Dahlberg, M. L., Edin, S., & Palmqvist, R. (2022) · Cancers · doi:10.3390/cancers14235937 · Cited by 30
Ugai, T., Akimoto, N., Haruki, K., Harrison, T. A., Cao, Y., Qu, C., Chan, A. T., Campbell, P. T., Berndt, S. I., Buchanan, D. D., et al. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-01955-2 · Cited by 30
Self-citationErfanian, N., Nasseri, S., Feriz, A. M., Safarpour, H., & Namaei, M. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-50047-x · Cited by 29
Cancer invasion and anaerobic bacteria: new insights into mechanisms
Hurst, R., Brewer, D. S., Gihawi, A., Wain, J. R., & Cooper, C. S. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001817 · Cited by 29
Periodontal pathogens and cancer development
Zhou, Y., Meyle, J., & Groeger, S. E. (2024) · Periodontology 2000 · doi:10.1111/prd.12590 · Cited by 29
Balancing the Oral–Gut–Brain Axis with Diet
Kerstens, R., Ng, Y. Z., Pettersson, S., & Jayaraman, A. (2024) · Nutrients · doi:10.3390/nu16183206 · Cited by 35
Hu, S., Heng, H., Yang, F., Wang, M., Liu, G., Xiang, Y., & Miao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1735873 · Cited by 32
Dysbiosis-Associated Polyposis of the Colon—Cap Polyposis
Okamoto, K., Watanabe, T., Komeda, Y., Okamoto, A., Minaga, K., Kamata, K., Yamao, K., Takenaka, M., Hagiwara, S., Sakurai, T., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00918 · Cited by 28
Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia
Amenábar, J. M., Torres‐Pereira, C. C., Tang, K. D., & Punyadeera, C. (2019) · Cancer · doi:10.1002/cncr.32435 · Cited by 28
Colov, E. P., Degett, T. H., Raskov, H., & Gögenür, I. (2020) · Apmis · doi:10.1111/apm.13032 · Cited by 28
Richardson, M., Ren, J., Rubinstein, M. R., Taylor, J. A., Friedman, R. A., Shen, B., & Han, Y. W. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1814120 · Cited by 28
Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer
Kurt, M., & Yumuk, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-81171-1 · Cited by 27
Triumph against cancer: invading colorectal cancer with nanotechnology
Vinchhi, P., & Patel, M. M. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1889512 · Cited by 28
Huangfu, S., Zhang, W.-B., Zhang, H., Yang, L., Zhang, Y., Nie, J.-L., Chu, X., Chen, C.-S., Jiang, H., & Pan, J. (2021) · Journal of Cancer · doi:10.7150/jca.50111 · Cited by 29
Sheikh, A. A., Taube, J. H., & Greathouse, K. L. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab060 · Cited by 26
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
Zhao, T., Wang, X., Fu, L., & Yang, K. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.144 · Cited by 30
Dingenen, L. V., Segers, C., Wouters, S., Mysara, M., Leys, N., Kumar‐Singh, S., Malhotra‐Kumar, S., & Houdt, R. V. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1298264 · Cited by 29
The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
Qi, X., Liu, Y., Hussein, S., Choi, G., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2022) · Cells · doi:10.3390/cells11223684 · Cited by 29
Bostanghadiri, N., Razavi, S., Shariati, A., Talebi, M., Mirkalantari, S., Razavi, À. E., & Darban‐Sarokhalil, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1302719 · Cited by 27
Wang, K., Lo, C., Mehta, R. S., Nguyen, L. H., Wang, Y., Ma, W., Ugai, T., Kawamura, H., Ugai, S., Takashima, Y., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.07.040 · Cited by 28
Self-citationRetractedSpatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance
Tan, Q., Cao, X., Zou, F., Wang, H., Xiong, L., & Deng, S. (2025) · Biomedicines · doi:10.3390/biomedicines13051261 · Cited by 30
Nie, S., Wang, A., & Yuan, Y. (2020) · Journal of Cancer · doi:10.7150/jca.50918 · Cited by 28
Effect of gut microbiota in the colorectal cancer and potential target therapy
Li, J., Zhu, Y., Yang, L., & Wang, Z. (2022) · Discover Oncology · doi:10.1007/s12672-022-00517-x · Cited by 29
He, Z., Tian, W., Wei, Q., & Xu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968649 · Cited by 27
The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host
Huang, J., & Mao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029033 · Cited by 27
Tumor SQSTM1 (p62) expression and T cells in colorectal cancer
Kosumi, K., Masugi, Y., Yang, J., Qian, Z. R., Kim, S. A., Li, W., Shi, Y. X., da Silva, A., Hamada, T., Liu, L., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1284720 · Cited by 28
Self-citationUmaña, A., Nguyen, T. T. D., Sanders, B. E., Williams, K. J., Wozniak, B., & Slade, D. J. (2022) · Journal of Bacteriology · doi:10.1128/jb.00279-22 · Cited by 24
Ectopic colonization by oral bacteria as an emerging theme in health and disease
Hernández‐Cabanyero, C., & Vonaesch, P. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae012 · Cited by 27
Pedrogo, D. A. M., Sears, C. L., & Melia, J. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae061 · Cited by 30
The Tissue-Associated Microbiota in Colorectal Cancer: A Systematic Review
da Costa, C. P., Vieira, P. F., Mendes-Rocha, M., Pereira‐Marques, J., Ferreira, R. M., & Figueiredo, C. (2022) · Cancers · doi:10.3390/cancers14143385 · Cited by 29
The Appendix Orchestrates T-Cell Mediated Immunosurveillance in Colitis-Associated Cancer
Collard, M. K., Tourneur‐Marsille, J., Uzzan, M., Albuquerque, M., Roy, M., Dumay, A., Freund, J., Hugot, J., Guedj, N., Tréton, X., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.016 · Cited by 27
Feng, X., Li, Z., Guo, W., & Hu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1087755 · Cited by 26
Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
Witt, R. G., Cass, S. H., Tran, T., Damania, A. V., Nelson, E. E., Sirmans, E., Burton, E. M., Chelvanambi, M., Johnson, S. B., Tawbi, H. A., et al. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2023.2955 · Cited by 26
Bruneau, A., Baylatry, M., Joly, A. C., & Sokol, H. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.10.025 · Cited by 30
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Shi, Z., Li, Z., & Zhang, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05640-7 · Cited by 26
Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis
Vecchia, M. L., Sala, G., Sculco, M., Aspesi, A., & Dianzani, I. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01505-x · Cited by 28
Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges
Morsli, D. S., Tbahriti, H. F., Rahli, F., Mahammi, F. Z., Nagdalian, A. A., Hemeg, H. A., Imran, M., Rauf, A., & Shariati, M. A. (2025) · Discover Oncology · doi:10.1007/s12672-025-01996-4 · Cited by 26
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
Kee, J. X., Yau, J. N. N., Muthuramalingam, R. P. K., Wang, X., Chng, W. H., Lopez‐Sanchez, A., Tay, K. K. W., Deng, L., Gibson, D., Bertrand, H. C., et al. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00041 · Cited by 29
Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer
Chen, W., Zhang, X., Zhang, Y.-P., Yue, C.-B., Wang, Y.-L., Pan, H., Zhang, Y., Liu, H., & Zhang, Y. (2022) · Current Medical Science · doi:10.1007/s11596-022-2597-1 · Cited by 26
Identification and validation of microbial biomarkers from cross-cohort datasets using xMarkerFinder
Gao, W., Lin, W., Li, Q., Chen, W., Yin, W., Zhu, X., Gao, S., Liu, L., Li, W., Wu, D., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-00999-9 · Cited by 24
Guo, S., Wang, H., Nian, Z., Wang, Y.-D., Zeng, Q., & Zhang, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-11127-x · Cited by 27
Chen, Y., Yang, Y., & Gu, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s240108 · Cited by 24
Șurlin, P., Nicolae, F. M., Şurlin, V., Pătrașcu, Ș., Ungureanu, B. S., Didilescu, A. C., & Gheonea, D. I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123885 · Cited by 25
Guo, X., Yu, K. G., & Huang, R. (2024) · Molecular Oral Microbiology · doi:10.1111/omi.12446 · Cited by 26
Shigematsu, Y., Saito, R., Amori, G., Kanda, H., Takahashi, Y., Takeuchi, K., Takahashi, S., & Inamura, K. (2024) · Cancer Science · doi:10.1111/cas.16315 · Cited by 25
The physical biogeography of Fusobacterium nucleatum in health and disease
Connolly, J. P., & Kelly, L. (2025) · mBio · doi:10.1128/mbio.02989-24 · Cited by 24
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer
Karta, J., Meyers, M., Rodriguez, F., Koncina, E., Gilson, C., Klein, E., Gabola, M., Benzarti, M., Escriva, P. P., Molina‐Tijeras, J. A., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00542-w · Cited by 26
Zhang, W., Chen, X., & Wong, K. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15500 · Cited by 25
Microbiome in drug resistance to colon cancer
Pandey, K. R., & Umar, S. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.100472 · Cited by 24
Oral pathogen in the pathogenesis of colorectal cancer
Yu, T., Zhou, Y., & Fang, J. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15743 · Cited by 25
Yu, T., Ji, L., Lou, L., Ye, S., Fang, X., Li, C., Jiang, F., Gao, H., Lou, Y., & Li, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.841157 · Cited by 24
Probiotics and live biotherapeutic products aiming at cancer mitigation and patient recover
Schemczssen-Graeff, Z., & Pileggi, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.921972 · Cited by 24
Elnaggar, J. H., Huynh, V. O., Lin, D., Hillman, R. T., Abana, C. O., Alam, M. B. E., Tomasic, K., Karpinets, T. V., Kouzy, R., Phan, J. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1051431 · Cited by 26
Relationships between gut microbiota, red meat consumption and colorectal cancer.
Diakité, M., Diakité, B., Koné, A., Balam, S., Fofana, D., Diallo, D., Kassogué, Y., Traoré, C. B., Kamaté, B., Ba, D. M., et al. (2022) · PubMed · Cited by 34
Nawab, S., Bao, Q., Ji, L., Luo, Q., Fu, X., Fan, S., Deng, Z., & Ma, W. (2023) · Microorganisms · doi:10.3390/microorganisms11082004 · Cited by 24
Wang, S., Xu, B., Zhang, Y., Chen, G., Zhao, P., Gao, Q., & Yuan, L. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0376 · Cited by 24
Koulouridi, A., Messaritakis, I., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2020) · Cancers · doi:10.3390/cancers13010043 · Cited by 26
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
Moskal, K., Khurana, N., Siegert, L., Lee, Y., Clevers, H. C., Elinav, E., & Puschhof, J. (2024) · International Journal of Cancer · doi:10.1002/ijc.35298 · Cited by 24
Ancient Thali Diet: Gut Microbiota, Immunity, and Health.
Shondelmyer, K., Knight, R. D., Sanivarapu, A., Ogino, S., & Vanamala, J. K. P. (2018) · Europe PMC (PubMed Central) · Cited by 23
Self-citationSerrated neoplasia in the colorectum: gut microbiota and molecular pathways
Kang, X., Zhang, R., Kwong, T. N. Y., Lui, R. N.-S., Wu, W. K. K., Sung, J. J. �., Yu, J. Q., & Wong, S. H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1863135 · Cited by 23
Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
Gaiani, F., Marchesi, F., Negri, F., Greco, L., Malesci, A., de’Angelis, G. L., & Laghi, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105246 · Cited by 24
Rye, M. S., Garrett, K. L., Holt, R. A., Platell, C. F. E., & McCoy, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262416 · Cited by 24
Gupta, I., Pedersen, S., Vranić, S., & Moustafa, A. A. (2022) · Cancers · doi:10.3390/cancers14122964 · Cited by 25
Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients.
Himbert, C., Stephens, W. Z., Gigic, B., Hardikar, S. S., Holowatyj, A. N., Lin, T., Ose, J., Swanson, E., Ashworth, A., Warby, C. A., et al. (2022) · PubMed Central · Cited by 24
The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer
Sillo, T. O., Beggs, A. D., Middleton, G., & Akingboye, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065767 · Cited by 25
Zhang, X., Wang, Y., Fan, R., Zhang, L., Li, Z., Zhang, Y., Zheng, W., Wang, L., Liu, B., & Quan, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00394-23 · Cited by 23
Ray, A., Moore, T., Pandit, R., Burke, A. D., & Borsch, D. M. (2023) · Biology · doi:10.3390/biology12070963 · Cited by 23
Liu, L., Liang, L., Luo, Y., Han, J., Lu, D., Cai, R., Sethi, G., & Mai, S. (2024) · Research · doi:10.34133/research.0529 · Cited by 22
Takashima, Y., Kawamura, H., Okadome, K., Ugai, S., Haruki, K., Arima, K., Mima, K., Akimoto, N., Nowak, J. A., Giannakis, M., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.01.013 · Cited by 22
Self-citationFusobacterium nucleatum : Unraveling its potential role in gastric carcinogenesis
Petkevičius, V., Lehr, K., Kupčinskas, J., & Link, A. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i35.3972 · Cited by 22
Cancer microbiota: a focus on tumor-resident bacteria
Vella, G., & Rescigno, M. (2025) · EMBO Reports · doi:10.1038/s44319-025-00482-w · Cited by 25
The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis
Mukherjee, A. G., Wanjari, U. R., Bradu, P., Murali, R., Kannampuzha, S., Loganathan, T., Doss, C. G. P., Arun Prakash, B. P., Renu, K., Dey, A., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103757 · Cited by 22
Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer
Kosumi, K., Baba, Y., Yamamura, K., Nomoto, D., Okadome, K., Yagi, T., Toihata, T., Kiyozumi, Y., Harada, K., Eto, K., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02112-x · Cited by 21
Self-citationOverexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer
Lv, Y., Nie, S., Zhou, J., Liu, F., Hu, Y., Jiang, J., Li, N., & Liu, J. (2016) · ANZ Journal of Surgery · doi:10.1111/ans.13617 · Cited by 22
Biomarker correlation network in colorectal carcinoma by tumor anatomic location
Nishihara, R., Glass, K., Mima, K., Hamada, T., Nowak, J. A., Qian, Z. R., Kraft, P. L., Giovannucci, E. L., Fuchs, C. S., Chan, A. T., et al. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1718-5 · Cited by 24
Self-citationHara, Y., Baba, Y., Oda, E., Harada, K., Yamashita, K., Toihata, T., Kosumi, K., Iwatsuki, M., Miyamoto, Y., Tsutsuki, H., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02753-0 · Cited by 21
Self-citationNoguti, J., Chan, A. A., Bandera, B. C., Brislawn, C., Protić, M., Sim, M., Jansson, J. K., Bilchik, A. J., & Lee, D. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25276 · Cited by 21
Self-citationFusobacterium�nucleatum‑positive colorectal cancer (Review)
Yang, Z., & Ji, G. (2019) · Oncology Letters · doi:10.3892/ol.2019.10433 · Cited by 20
The Link between Fusobacteria and Colon Cancer: a Fulminant Example and Review of the Evidence
King, M., Hurley, H., Davidson, K. R., Dempsey, E. C., Barron, M. A., Chan, E. D., & Frey, A. (2020) · Immune Network · doi:10.4110/in.2020.20.e30 · Cited by 21
Fusobacterium nucleatum produces cancer stem cell characteristics via EMT-resembling variations.
Wang, Q. L., Chen, Y., Yue, C., & Liu, X. (2020) · PubMed Central · Cited by 21
Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer
Yao, Q., Tang, M., Zeng, L., Chu, Z., Sheng, H., Zhang, Y., Zhou, Y., Zhang, H., Jiang, H., & Ye, M. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02182-6 · Cited by 21
Characterization of the consensus mucosal microbiome of colorectal cancer
Zhao, L., Grimes, S. M., Greer, S., Kubit, M. A., Lee, H., Nadauld, L. D., & Ji, H. P. (2021) · NAR Cancer · doi:10.1093/narcan/zcab049 · Cited by 20
The intestinal microbiota in colorectal cancer metastasis – Passive observer or key player?
Patel, M., McAllister, M. J., Nagaraju, R. T., Al-Badran, S. S. F., Edwards, J., McBain, A. J., Barriuso, J., & Aziz, O. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103856 · Cited by 21
Gut microbiota display alternative profiles in patients with early-onset colorectal cancer
Xiong, H., Wang, J., Chang, Z., Hu, H., Yuan, Z., Zhu, Y., Hu, Z., Wang, C., Liu, Y., Wang, Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1036946 · Cited by 23
The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity
Huynh, M., Crane, M. J., & Jamieson, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1094110 · Cited by 22
Li, S., Wang, T., Ren, Y., Liu, Z., Gao, J., & Guo, Z. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02419-7 · Cited by 23
Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset
Kharrat, N., Assidi, M., Abu-Elmagd, M. M., Pushparaj, P. N., Alkhaldy, A. A., Arfaoui, L., Naseer, M. I., Omri, A. E., Messaoudi, S. A., Buhmeida, A. S., et al. (2019) · Bioinformation · doi:10.6026/97320630015372 · Cited by 23
Toomey, S., Gunther, J. R., Carr, A., Weksberg, D. C., Thomas, V., Salvucci, M., Bacon, O., Sherif, E.-M., Fay, J., Kay, E. W., et al. (2020) · Cancers · doi:10.3390/cancers12071808 · Cited by 21
The gut microbiome: what every gastroenterologist needs to know
Mullish, B. H., Quraishi, M. N., Segal, J. P., Ianiro, G., & Iqbal, T. H. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101376 · Cited by 21
Lee, S., & Lee, I. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2375679 · Cited by 22
Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection
Sorino, J., Mura, M. D., Ingravallo, G., Cazzato, G., Pizzimenti, C., Zuccalà, V., Pepe, L. R., Germanà, E., Martini, M., Ieni, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167915 · Cited by 22
Deciphering the personalized functional redundancy hierarchy in the gut microbiome
Jiang, Y., Che, L., & Li, S. C. (2025) · Microbiome · doi:10.1186/s40168-025-02273-w · Cited by 23
Role of the gut microbiome in Alzheimer’s disease
Chok, K. C., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0122 · Cited by 22
Gut microbes in gastrointestinal cancers
Wang, F., Song, M., Lu, X., Zhu, X., & Deng, J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.037 · Cited by 21
Self-citationCore Microbiota Promotes the Development of Dental Caries
Chen, J., Kong, L., Peng, X., Chen, Y., Ren, B., Li, M., Li, J., Zhou, X., & Cheng, L. (2021) · Applied Sciences · doi:10.3390/app11083638 · Cited by 20
Metadata
- Authors
- Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A. D., Giannakis, M., Bullman, S., Milner, D. A., Baba, H., Giovannucci, E. L., Garraway, L. A., Freeman, G. J., Dranoff, G., Garrett, W. S., Huttenhower, C., Meyerson, M., Meyerhardt, J. A., Chan, A. T., Fuchs, C. S., & Ogino, S.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Kumamoto University (JP)
- Corresponding author
- Ogino, Shuji
- ORCID
- Mima, Kosuke
- Nishihara, Reiko
- Qian, Zhi Rong
- Cao, Yin
- Sukawa, Yasutaka
- Nowak, Jonathan A
- Yang, Juhong
- Dou, Ruoxu
- Masugi, Yohei
- Song, Mingyang
- Kostic, Aleksandar D
- Giannakis, Marios
- Bullman, Susan
- Milner, Danny A
- Baba, Hideo
- Giovannucci, Edward L
- Garraway, Levi A
- Freeman, Gordon J
- Dranoff, Glenn
- Garrett, Wendy S
- Huttenhower, Curtis
- Meyerson, Matthew
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Fuchs, Charles S
- Ogino, Shuji
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-08-26
- Volume
- 65
- Issue
- 12
- Pages
- 1973-1980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4769120
- OpenAlex
- W2199896469
- Cited by
- 1,080
- References
- 53
- Citations by year
- 2026: 108 · 2025: 116 · 2024: 131 · 2023: 119 · 2022: 141 · 2021: 140 · 2020: 105 · 2019: 71 · 2018: 64 · 2017: 47 · 2016: 34 · 2015: 4
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR001100)
- National Cancer Institute (P50CA127003, R01CA151993, R01CA118553, R01CA137178, R35CA197735, P01CA087969, R01CA169141, K07CA122826, P01CA055075, UM1CA186107, UM1CA167552, K07CA190673, R01CA154426)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, rectal cancer, colon cancer, prognosis, colorectal cancer-specific mortality, tumor microbiome, microsatellite instability, CpG island methylator phenotype, BRAF mutation, prognostic factors, gut microbiota, antitumor immunity
- MeSH terms
- Aged, Carcinoma, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Phenotype, Prognosis, Prospective Studies, Research Design, Biomarkers, Tumor, Colorectal Neoplasms, Databases, Factual, Proto-Oncogene Proteins p21(ras), Fusobacterium nucleatum, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins B-raf, Kaplan-Meier Estimate, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
